Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors

Journal of Periodontal Research

Volumn 44, Issue 6, 2009, Pages 736-743

  Thangjam, G S ^a   Agarwal, P ^a   Balapure, A K ^b   Girish Rao, S ^c   Kondaiah, P ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c RV Dental College and Hospital   (India)

Author keywords

Collagen; Gingival fibroblasts; Keratinocytes; Transforming growth factor beta2

Indexed keywords

1,2-BIS(2-AMINOPHENOXY)ETHANE-N,N,N',N'-TETRAACETIC ACID; ARECOLINE; CHELATING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; COL3A1 PROTEIN, HUMAN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 6; COLLAGEN TYPE 7; COLLAGEN TYPE I, ALPHA 1 CHAIN; DRUG DERIVATIVE; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; ISOPROTEIN; MUSCARINIC M3 RECEPTOR; PROTEIN KINASE C; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROBLAST; GENETICS; GINGIVA; HUMAN; KERATINOCYTE; MOUTH DISEASE; MOUTH MUCOSA; PATHOLOGY;

ARECOLINE; CELL LINE; CHELATING AGENTS; CHOLINERGIC AGONISTS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; COLLAGEN TYPE IV; COLLAGEN TYPE VI; COLLAGEN TYPE VII; DOWN-REGULATION; EGTAZIC ACID; EXTRACELLULAR MATRIX; FIBROBLASTS; GINGIVA; HUMANS; KERATINOCYTES; MOUTH MUCOSA; ORAL SUBMUCOUS FIBROSIS; PROTEIN ISOFORMS; PROTEIN KINASE C; RECEPTOR, MUSCARINIC M3; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 70350514105     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2008.01185.x     Document Type: Article

References (30)

1. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966 22 : 764 779.
2. Mani NJ, Singh B. Studies on oral submucous fibrosis. III. Epithelial changes. Oral Surg Oral Med Oral Pathol 1976 41 : 203 214.
3. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 2006 42 : 561 568.
4. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 1998 10 : 713 719.
5. Feng Y, Ling T. Changes of cytokines secreted by human oral mucosa keratinocytes from oral submucous fibrosis in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi 2000 18 : 23 25.
6. Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 1985 6 : 295 303.
7. Kaur J, Rao M, Chakravarti N et al. Co-expression of colligin and collagen in oral submucous fibrosis: plausible role in pathogenesis. Oral Oncol 2001 37 : 282 287.
8. Meghji S, Scutt A, Harvey W, Canniff JP. An in-vitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol 1987 32 : 213 215.
9. Harvey W, Scutt A, Meghji S, Canniff JP. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 1986 31 : 45 49.
10. Jeng JH, Lan WH, Hahn LJ, Hsieh CC, Kuo MY. Inhibition of the migration, attachment, spreading, growth and collagen synthesis of human gingival fibroblasts by arecoline, a major areca alkaloid, in vitro. J Oral Pathol Med 1996 25 : 371 375.
11. Ghelardini C, Galeotti N, Lelli C, Bartolini A. M1 receptor activation is a requirement for arecoline analgesia. Farmaco 2001 56 : 383 385.
12. Xie DP, Chen LB, Liu CY, Zhang CL, Liu KJ, Wang PS. Arecoline excites the colonic smooth muscle motility via M-3 receptor in rabbits. Chin J Physiol 2004 47 : 89 94.
13. Yang YR, Chang KC, Chen CL, Chiu TH. Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol 2000 43 : 23 28.
14. Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 1995 9 : 619 625.
15. Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC. Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res 1989 49 : 5294 5298.
16. Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY. Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol 1999 37 : 751 756.
17. Verrecchia F, Mauviel A. Transforming growth factor-beta and fibrosis. World J Gastroenterol 2007 13 : 3056 3062.
18. Wakefield LM, Smith DM, Flanders KC, Sporn MB. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem 1988 263 : 7646 7654.
19. Metzger M, Just L, Boss A, Drews U. Identification and functional characterization of the muscarinic receptor M-3 in the human keratinocyte cell line HaCaT. Cells Tissues Organs 2005 180 : 96 105.
20. Ducibella T, Fissore R. The roles of Ca2+, downstream protein kinases, and oscillatory signaling in regulating fertilization and the activation of development. Dev Biol 2008 315 : 257 279.
21. Li X, Ling TY, Gao YJ. Effect of arecoline on the differentiation of myofibroblasts of oral mucosa. Zhonghua Kou Qiang Yi Xue Za Zhi 2007 42 : 423 427.
22. Kuo MY, Chen HM, Hahn LJ, Hsieh CC, Chiang CP. Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 1995 74 : 1783 1788.
23. Kato M, Ishizaki A, Hellman U et al. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-beta and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J Biol Chem 1995 270 : 12373 12379.
24. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988 106 : 761 771.
25. Ndoye A, Buchli R, Greenberg B et al. Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Dermatol 1998 111 : 410 416.
26. Buchli R, Ndoye A, Rodriguez JG, Zia S, Webber RJ, Grando SA. Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors. J Cell Biochem 1999 74 : 264 277.
27. Buchli R, Ndoye A, Arredondo J, Webber RJ, Grando SA. Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes. Mol Cell Biochem 2001 228 : 57 72.
28. Arredondo J, Hall LL, Ndoye A, Chernyavsky AI, Jolkovsky DL, Grando SA. Muscarinic acetylcholine receptors regulating cell cycle progression are expressed in human gingival keratinocytes. J Periodont Res 2003 38 : 79 89.
29. Wen XM, Zhang YL, Liu XM, Guo SX, Wang H. Immune responses in mice to arecoline mediated by lymphocyte muscarinic acetylcholine receptor. Cell Biol Int 2006 30 : 1048 1053.
30. Lawrence DA, Pircher R, Kryceve-Martinerie C, Jullien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 1984 121 : 184 188.